Sphera Funds Management Ltd. 13D and 13G filings for Chemomab Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 5:25 pm Sale | 2025-03-31 | 13G | Chemomab Therapeutics Ltd. CMMB | Sphera Funds Management Ltd. | 225,107 4.780% | -78,537 (-25.86%) | Filing |
| 2024-08-20 2:36 pm Purchase | 2024-07-25 | 13G | Chemomab Therapeutics Ltd. CMMB | Sphera Funds Management Ltd. | 303,644 6.560% | 303,644 (New Position) | Filing |